CD4 and multiple sclerosis: In a murine model of multiple sclerosis (experimental autoimmune encephalomyelitis, EAE), ACE inhibitors suppressed Th17 cells and induction of CD4+FoxP3+ Treg cells, together with activation of the alternative NF-κB2 pathway [229,230].